Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

Forecasting and valuation tool designed specifically for new drug candidates


By Jesse Schwartz
Published: July 25th, 2018

Easy eNPV is a tool that provides its users with unprecedented ability to efficiently and accurately forecast the financial performance of new drug candidates and produce valuations. It is not a costly subscription product — some of which run in the tens of thousands for a year. Rather, it’s available for one-time purchase — with unlimited use — at a very modest price.  

Valuation and forecasting for new drug candidates is critical in directing product strategy, attracting licensees, and communicating potential value to investors — but generic financial models are simply not equipped to handle the unique complexities associated with pharmaceuticals and biotechnology. With the Easy eNPV valuation and forecasting tool, users have a fully automated and user-friendly model that efficiently facilitates this vital strategic task in drug development and licensing.

The Easy eNPV model was developed by serial life sciences entrepreneur Justin A. Miller, MBA, and is offered under a special discount arrangement with 2Market Information Inc., publisher of Tech Transfer eNews. For complete details, CLICK HERE >>

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment